Market Sentiment Bifurcates: What 10 Niche Equities Signal About the Broader EconomyGlobal Report·Aug 7 at 04:18 AMGNPX-9.07%FIVN+8.03%
The Market's Island of Misfit Toys: Who's Faking It and Who's Actually Making MoneyGlobal Report·Aug 6 at 04:15 AMNYT-0.44%NWL-1.34%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Aug 4 at 12:05 PMAMIX-11.76%ADGM-0.33%
Exagen Q2 FY26 net loss narrows 28% to $3.2 million; revenue rises 16% to $19.9 millionPUBT·Aug 4 at 07:09 AMXGN-1.96%
Exagen | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 19.94 MEarnings Watch·Aug 4 at 07:04 AMXGN-1.96%
Exagen management to join Canaccord Genuity Annual Growth Conference fireside chatPUBT·Jul 28 at 08:38 AMXGN-1.96%
Exagen Wins Buy Rating on Strong Q1 Beat, Improving Fundamentals and Clear Path to EBITDA BreakevenTip Ranks·May 12 at 10:15 AMXGN-1.96%
Exagen’s Risk Profile Remains Unchanged: Stable Yet Persistent Exposures Keep Investors on AlertTip Ranks·May 12 at 01:00 AMXGN-1.96%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·May 11 at 12:05 PMHRTX+6.37%BMY-0.92%
Exagen shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 sales guidance.benzinga_article·May 11 at 11:14 AMXGN-1.96%
